Page last updated: 2024-09-02

tanshinone and tanshinone ii a

tanshinone has been researched along with tanshinone ii a in 13 studies

Compound Research Comparison

Studies
(tanshinone)
Trials
(tanshinone)
Recent Studies (post-2010)
(tanshinone)
Studies
(tanshinone ii a)
Trials
(tanshinone ii a)
Recent Studies (post-2010) (tanshinone ii a)
1,445101,03361041

Protein Interaction Comparison

ProteinTaxonomytanshinone (IC50)tanshinone ii a (IC50)
Chain A, RNA-directed RNA polymerase NS5Dengue virus 2 16681-PDK53100
Apoptotic peptidase activating factor 1Homo sapiens (human)4.82
Spike glycoproteinBetacoronavirus England 10.8
Replicase polyprotein 1abBetacoronavirus England 10.8
caspase-9 isoform alpha precursorHomo sapiens (human)11.2
caspase-3 isoform a preproproteinHomo sapiens (human)11.2
Telomerase reverse transcriptaseHomo sapiens (human)2.75
Transmembrane protease serine 2Homo sapiens (human)0.8
Procathepsin LHomo sapiens (human)0.8
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)1.14
Replicase polyprotein 1aSevere acute respiratory syndrome-related coronavirus1.2
Replicase polyprotein 1abHuman coronavirus 229E0.8
Replicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus0.8
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 21.1855
Aldo-keto reductase family 1 member B1Homo sapiens (human)8.69
Tyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)2.14
Spike glycoproteinSevere acute respiratory syndrome-related coronavirus0.8
Tyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)2.59
Hypoxia-inducible factor 1-alphaHomo sapiens (human)6.855
Endothelial PAS domain-containing protein 1Homo sapiens (human)6.855
Angiotensin-converting enzyme 2 Homo sapiens (human)0.8

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (15.38)29.6817
2010's8 (61.54)24.3611
2020's3 (23.08)2.80

Authors

AuthorsStudies
Bastow, KF; Don, MJ; Lee, KH; Lin, YL; Nakamura, S; Sun, CM; Wang, X; Wu, TS; Yu, HJ1
Dat, NT; Hong, YS; Jin, X; Kim, YH; Lee, D; Lee, JH; Lee, JJ; Lee, K1
Cheung, CC; Fung, KP; Lai, PB; Lee, WY; Liu, KW; Wong, J; Yeung, JH1
Adams, M; Fronza, M; Hamburger, M; Heinzmann, B; Laufer, S; Merfort, I; Murillo, R; ƚlusarczyk, S1
Jarstfer, MB; Keppler, BR; Lee, KH; Soares, J; Wang, X1
Jeong, HJ; Kim, DW; Kim, JH; Kim, YM; Kwon, HJ; Lee, WS; Park, JY; Park, KH; Park, SJ; Ryu, YB1
Edwards, CC; Hatfield, MJ; Hyatt, JL; Jeffries, C; Lemoff, A; Potter, PM; Tsurkan, LG; Yan, B1
Liu, W; Loh, ML; Qu, CK; Tang, LD; Xu, G; Xu, WR; Yu, B1
Byun, BJ; Chae, CH; Cho, H; Choi, G; Kim, HY; Lee, JY; Park, WK; Ryu, SY; Woo, J1
Cheung, J; Gary, EN; Rosenberry, TL; Shiomi, K1
Banerjee, J; Biswas, N; Bural, S; Dey, A; Gain, C; Kar, GK; Rakshit, M; Saha, A; Sarkar, A1
Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW1
Hu, Y; Jadhav, P; Tan, B; Tan, H; Wang, J1

Reviews

1 review(s) available for tanshinone and tanshinone ii a

ArticleYear
Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease.
    Journal of medicinal chemistry, 2022, 06-09, Volume: 65, Issue:11

    Topics: Antiviral Agents; Coronavirus Papain-Like Proteases; COVID-19 Drug Treatment; Humans; Pandemics; Protease Inhibitors; SARS-CoV-2

2022

Other Studies

12 other study(ies) available for tanshinone and tanshinone ii a

ArticleYear
Antitumor Agents. 239. Isolation, structure elucidation, total synthesis, and anti-breast cancer activity of neo-tanshinlactone from Salvia miltiorrhiza.
    Journal of medicinal chemistry, 2004, Nov-04, Volume: 47, Issue:23

    Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Furans; Humans; Pyrones; Receptor, ErbB-2; Receptors, Estrogen; Salvia miltiorrhiza

2004
Abietane diterpenes from Salvia miltiorrhiza inhibit the activation of hypoxia-inducible factor-1.
    Journal of natural products, 2007, Volume: 70, Issue:7

    Topics: Abietanes; Antineoplastic Agents, Phytogenic; Dose-Response Relationship, Drug; Humans; Hypoxia-Inducible Factor 1; Korea; Plants, Medicinal; Salvia miltiorrhiza; Tumor Cells, Cultured

2007
Cytotoxic effects of tanshinones from Salvia miltiorrhiza on doxorubicin-resistant human liver cancer cells.
    Journal of natural products, 2010, May-28, Volume: 73, Issue:5

    Topics: Abietanes; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Doxorubicin; Drug Resistance, Neoplasm; Humans; Models, Biological; Molecular Structure; Phenanthrenes; Plants, Medicinal; Salvia miltiorrhiza

2010
In vitro cytotoxic activity of abietane diterpenes from Peltodon longipes as well as Salvia miltiorrhiza and Salvia sahendica.
    Bioorganic & medicinal chemistry, 2011, Aug-15, Volume: 19, Issue:16

    Topics: Abietanes; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cytotoxins; Drug Screening Assays, Antitumor; Humans; Lamiaceae; Phytotherapy; Plant Extracts; Plant Roots; Salvia; Structure-Activity Relationship

2011
ortho-Quinone tanshinones directly inhibit telomerase through an oxidative mechanism mediated by hydrogen peroxide.
    Bioorganic & medicinal chemistry letters, 2011, Dec-15, Volume: 21, Issue:24

    Topics: Abietanes; Benzoquinones; Catalase; Cell Line, Tumor; Dithiothreitol; Enzyme Activation; Enzyme Inhibitors; Humans; Hydrogen Peroxide; Oxidation-Reduction; Telomerase

2011
Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases.
    Bioorganic & medicinal chemistry, 2012, Oct-01, Volume: 20, Issue:19

    Topics: Abietanes; Cysteine Proteinase Inhibitors; Humans; Kinetics; Protein Binding; Salvia miltiorrhiza; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Ubiquitination

2012
Modulation of esterified drug metabolism by tanshinones from Salvia miltiorrhiza ("Danshen").
    Journal of natural products, 2013, Jan-25, Volume: 76, Issue:1

    Topics: Abietanes; Algorithms; Camptothecin; Carboxylesterase; Clinical Trials, Phase I as Topic; Drugs, Chinese Herbal; Herb-Drug Interactions; Humans; Irinotecan; Medicine, Chinese Traditional; Molecular Structure; Phenanthrolines; Plant Roots; Salvia miltiorrhiza

2013
Identification of cryptotanshinone as an inhibitor of oncogenic protein tyrosine phosphatase SHP2 (PTPN11).
    Journal of medicinal chemistry, 2013, Sep-26, Volume: 56, Issue:18

    Topics: Animals; Catalytic Domain; Cell Line, Tumor; Computer-Aided Design; Drug Evaluation, Preclinical; Enzyme Activation; Enzyme Inhibitors; Humans; Mice; Models, Molecular; Mutation; Phenanthrenes; Protein Tyrosine Phosphatase, Non-Receptor Type 11

2013
Biological evaluation of tanshindiols as EZH2 histone methyltransferase inhibitors.
    Bioorganic & medicinal chemistry letters, 2014, Jun-01, Volume: 24, Issue:11

    Topics: Abietanes; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enhancer of Zeste Homolog 2 Protein; Enzyme Inhibitors; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Humans; Molecular Conformation; Polycomb Repressive Complex 2; Structure-Activity Relationship

2014
Structures of human acetylcholinesterase bound to dihydrotanshinone I and territrem B show peripheral site flexibility.
    ACS medicinal chemistry letters, 2013, Nov-14, Volume: 4, Issue:11

    Topics:

2013
Identification of two novel thiophene analogues as inducers of autophagy mediated cell death in breast cancer cells.
    Bioorganic & medicinal chemistry, 2021, 05-01, Volume: 37

    Topics: Antineoplastic Agents; Apoptosis; Autophagy; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Thiophenes; Unfolded Protein Response

2021
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
    Journal of medicinal chemistry, 2021, 12-09, Volume: 64, Issue:23

    Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors

2021